BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21062482)

  • 21. Mutations of phosphatase and tensin homolog deleted from chromosome 10 in canine hemangiosarcoma.
    Dickerson EB; Thomas R; Fosmire SP; Lamerato-Kozicki AR; Bianco SR; Wojcieszyn JW; Breen M; Helfand SC; Modiano JF
    Vet Pathol; 2005 Sep; 42(5):618-32. PubMed ID: 16145208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular profiling of pancreatic neuroendocrine tumors in sporadic and Von Hippel-Lindau patients.
    Speisky D; Duces A; Bièche I; Rebours V; Hammel P; Sauvanet A; Richard S; Bedossa P; Vidaud M; Murat A; Niccoli P; Scoazec JY; Ruszniewski P; Couvelard A;
    Clin Cancer Res; 2012 May; 18(10):2838-49. PubMed ID: 22461457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Von Hippel-Lindau mutations disrupt vascular patterning and maturation via Notch.
    Arreola A; Payne LB; Julian MH; de Cubas AA; Daniels AB; Taylor S; Zhao H; Darden J; Bautch VL; Rathmell WK; Chappell JC
    JCI Insight; 2018 Feb; 3(4):. PubMed ID: 29467323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative Genomics Reveals Shared Mutational Landscape in Canine Hemangiosarcoma and Human Angiosarcoma.
    Megquier K; Turner-Maier J; Swofford R; Kim JH; Sarver AL; Wang C; Sakthikumar S; Johnson J; Koltookian M; Lewellen M; Scott MC; Schulte AJ; Borst L; Tonomura N; Alfoldi J; Painter C; Thomas R; Karlsson EK; Breen M; Modiano JF; Elvers I; Lindblad-Toh K
    Mol Cancer Res; 2019 Dec; 17(12):2410-2421. PubMed ID: 31570656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromatin run-on sequencing analysis finds that ECM remodeling plays an important role in canine hemangiosarcoma pathogenesis.
    Mukai C; Choi E; Sams KL; Klampen EZ; Anguish L; Marks BA; Rice EJ; Wang Z; Choate LA; Chou SP; Kato Y; Miller AD; Danko CG; Coonrod SA
    BMC Vet Res; 2020 Jun; 16(1):206. PubMed ID: 32571313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients.
    Igreja C; Courinha M; Cachaço AS; Pereira T; Cabeçadas J; da Silva MG; Dias S
    Haematologica; 2007 Apr; 92(4):469-77. PubMed ID: 17488657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular endothelial growth factor-B and vascular endothelial growth factor-C expression in renal cell carcinomas: regulation by the von Hippel-Lindau gene and hypoxia.
    Gunningham SP; Currie MJ; Han C; Turner K; Scott PA; Robinson BA; Harris AL; Fox SB
    Cancer Res; 2001 Apr; 61(7):3206-11. PubMed ID: 11306510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway.
    Blancher C; Moore JW; Robertson N; Harris AL
    Cancer Res; 2001 Oct; 61(19):7349-55. PubMed ID: 11585776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequencing of the von Hippel-Lindau gene in canine renal carcinoma.
    Pressler BM; Williams LE; Ramos-Vara JA; Anderson KI
    J Vet Intern Med; 2009; 23(3):592-7. PubMed ID: 19422471
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biological and molecular characterization of a canine hemangiosarcoma-derived cell line.
    Thamm DH; Dickerson EB; Akhtar N; Lewis R; Auerbach R; Helfand SC; MacEwen EG
    Res Vet Sci; 2006 Aug; 81(1):76-86. PubMed ID: 16256156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma.
    Edeline J; Mottier S; Vigneau C; Jouan F; Perrin C; Zerrouki S; Fergelot P; Patard JJ; Rioux-Leclercq N
    Hum Pathol; 2012 Nov; 43(11):1982-90. PubMed ID: 22626276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide association study identifies shared risk loci common to two malignancies in golden retrievers.
    Tonomura N; Elvers I; Thomas R; Megquier K; Turner-Maier J; Howald C; Sarver AL; Swofford R; Frantz AM; Ito D; Mauceli E; Arendt M; Noh HJ; Koltookian M; Biagi T; Fryc S; Williams C; Avery AC; Kim JH; Barber L; Burgess K; Lander ES; Karlsson EK; Azuma C; Modiano JF; Breen M; Lindblad-Toh K
    PLoS Genet; 2015 Feb; 11(2):e1004922. PubMed ID: 25642983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of drug-resistant subpopulations in canine hemangiosarcoma.
    Khammanivong A; Gorden BH; Frantz AM; Graef AJ; Dickerson EB
    Vet Comp Oncol; 2016 Sep; 14(3):e113-25. PubMed ID: 25112808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
    Zia MK; Rmali KA; Watkins G; Mansel RE; Jiang WG
    Int J Mol Med; 2007 Oct; 20(4):605-11. PubMed ID: 17786294
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cellular atypia is negatively correlated with immunohistochemical reactivity of CD31 and vWF expression levels in canine hemangiosarcoma.
    Maharani A; Aoshima K; Onishi S; Gulay KCM; Kobayashi A; Kimura T
    J Vet Med Sci; 2018 Feb; 80(2):213-218. PubMed ID: 29311493
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
    Jensen RL; Gillespie D; House P; Layfield L; Shelton C
    J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of platelet-derived growth factor and its receptors in spontaneous canine hemangiosarcoma and cutaneous hemangioma.
    Asa SA; Murai A; Murakami M; Hoshino Y; Mori T; Maruo K; Khater A; El-Sawak A; el-Aziz EA; Yanai T; Sakai H
    Histol Histopathol; 2012 May; 27(5):601-7. PubMed ID: 22419024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal cell carcinoma- and pheochromocytoma-specific altered gene expression profiles in VHL mutant clones.
    Tsuchiya MI; Okuda H; Takaki Y; Baba M; Hirai S; Ohno S; Shuin T
    Oncol Rep; 2005 Jun; 13(6):1033-41. PubMed ID: 15870918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
    Stratmann R; Krieg M; Haas R; Plate KH
    J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of simvastatin on cell proliferation and Ras activation in canine tumour cells.
    Kobayashi K; Baba K; Kambayashi S; Okuda M
    Vet Comp Oncol; 2021 Mar; 19(1):99-108. PubMed ID: 32779819
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.